124 related articles for article (PubMed ID: 1997848)
21. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands.
McCarthy GM; McCarty DJ
J Rheumatol; 1992 Apr; 19(4):604-7. PubMed ID: 1375648
[TBL] [Abstract][Full Text] [Related]
22. The management of oral mexiletine and intravenous lidocaine to treat chronic painful symmetrical distal diabetic neuropathy.
Ackerman WE; Colclough GW; Juneja MM; Bellinger K
J Ky Med Assoc; 1991 Oct; 89(10):500-1. PubMed ID: 1744511
[TBL] [Abstract][Full Text] [Related]
23. Capsaicin--an effective topical treatment in pain.
Markovits E; Gilhar A
Int J Dermatol; 1997 Jun; 36(6):401-4. PubMed ID: 9248881
[No Abstract] [Full Text] [Related]
24. The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy.
Forst T; Pohlmann T; Kunt T; Goitom K; Schulz G; Löbig M; Engelbach M; Beyer J; Pfützner A
Acta Diabetol; 2002 Apr; 39(1):1-6. PubMed ID: 12043933
[TBL] [Abstract][Full Text] [Related]
25. The effectiveness of topically applied capsaicin. A meta-analysis.
Zhang WY; Li Wan Po A
Eur J Clin Pharmacol; 1994; 46(6):517-22. PubMed ID: 7995318
[TBL] [Abstract][Full Text] [Related]
26. Topical nitrates in painful diabetic neuropathy.
Morton A
Aust Fam Physician; 2013 May; 42(5):263. PubMed ID: 23936935
[No Abstract] [Full Text] [Related]
27. New drug update: capsaicin.
Campbell RK; Baker DE
Diabetes Educ; 1990; 16(4):313-6. PubMed ID: 2357923
[No Abstract] [Full Text] [Related]
28. A randomized controlled trial comparing treatment regimens for acute pain for topical oleoresin capsaicin (pepper spray) exposure in adult volunteers.
Barry JD; Hennessy R; McManus JG
Prehosp Emerg Care; 2008; 12(4):432-7. PubMed ID: 18924005
[TBL] [Abstract][Full Text] [Related]
29. Diabetic peripheral neuropathy.
Hieronymus L; Borders J
Diabetes Self Manag; 2007; 24(5):90-3. PubMed ID: 18046821
[No Abstract] [Full Text] [Related]
30. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
31. Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review.
Goodwin B; Chiplunkar M; Salerno R; Coombs K; Sannoh U; Shah V; Averell N; Al-Shebab U; Janora D
Pain Manag; 2023 May; 13(5):309-316. PubMed ID: 37435696
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.
Babbar S; Marier JF; Mouksassi MS; Beliveau M; Vanhove GF; Chanda S; Bley K
Ther Drug Monit; 2009 Aug; 31(4):502-10. PubMed ID: 19494795
[TBL] [Abstract][Full Text] [Related]
33. [New concepts in the pathophysiology, diagnosis and treatment of neuropathic pain].
Suter MR; Sprenger T; Taub E; Besson M
Rev Med Suisse; 2013 Jun; 9(392):1346, 1348-50. PubMed ID: 23882911
[TBL] [Abstract][Full Text] [Related]
34. It's not just about rubbing--topical capsaicin and topical salicylates may be useful as adjuvants to conventional pain treatment.
Tramèr MR
BMJ; 2004 Apr; 328(7446):998. PubMed ID: 15105325
[No Abstract] [Full Text] [Related]
35. Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.
Yilmaz ME; Kadiroglu AK; Kara IH; Dikici S
MedGenMed; 2002 Aug; 4(3):23. PubMed ID: 12466766
[No Abstract] [Full Text] [Related]
36. Influence of topical capsaicin on facial sensitivity in response to experimental pain.
Lee YS; Kho HS; Kim YK; Chung SC
J Oral Rehabil; 2007 Jan; 34(1):9-14. PubMed ID: 17207073
[TBL] [Abstract][Full Text] [Related]
37. Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.
Guldiken S; Guldiken B; Arikan E; Altun Ugur B; Kara M; Tugrul A
Diabetes Nutr Metab; 2004 Aug; 17(4):247-9. PubMed ID: 15575347
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice.
Rashid MH; Inoue M; Bakoshi S; Ueda H
J Pharmacol Exp Ther; 2003 Aug; 306(2):709-17. PubMed ID: 12724350
[TBL] [Abstract][Full Text] [Related]
39. [Sensory disorder and clinical care in painful diabetic neuropathy].
Suzuki K; Kimura M
Nihon Rinsho; 2002 Oct; 60 Suppl 10():240-4. PubMed ID: 12430235
[No Abstract] [Full Text] [Related]
40. Topical capsaicin as an adjuvant analgesic.
Watson CP
J Pain Symptom Manage; 1994 Oct; 9(7):425-33. PubMed ID: 7822881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
